UIH(SH:688271)2026-03-01 17:23Summary of United Imaging (688271.SS) FY25 Preliminary Results Conference Call Company Overview - Company: United Imaging - Ticker: 688271.SS - Industry: Medical Imaging Equipment Key Financial Highlights - FY25 Preliminary Results: - Revenue: Rmb 13,821 million, representing a 34% year-over-year (yoy) increase [1] - Net Profit: Rmb 1,888 million, reflecting a 50% yoy growth [1] - 4Q25 Revenue Growth: Implied 48% yoy growth [1] - Anticipated growth for 4Q25: - Domestic Business: 44% yoy - Overseas Business: 61% yoy - Full Year FY25E Growth: - Domestic: 30% yoy - Overseas: 49% yoy [2] Factors Contributing to Performance 1. Continuous launch of innovative products, including high-end equipment like PCCT and ultrasound product line [1] 2. Rapid growth in overseas business due to increased market recognition and improved global marketing and service systems [1] 3. Successful promotion of domestic trade-in policies [1] Revenue Distribution by Geography - China Domestic Revenue: - 1H25A: Rmb 4,873 million (10.7% yoy) - 3Q25A: Rmb 1,993 million (73.3% yoy) - 4Q25E: Rmb 3,578 million (44.1% yoy) - FY25E: Rmb 10,444 million (30.0% yoy) [2] - Overseas Revenue: - 1H25A: Rmb 1,142 million (22.4% yoy) - 3Q25A: Rmb 851 million (80.7% yoy) - 4Q25E: Rmb 1,383 million (60.5% yoy) - FY25E: Rmb 3,376 million (49.0% yoy) [2] Future Outlook and Adjustments - Despite strong preliminary results, the company’s 2026E revenue forecast remains unchanged due to high base pressure from hospital bidding in China in 1H26 [2] - Continuous optimism about the company’s growth due to innovative products, overseas expansion, and increasing recurring revenue proportion [2] Investment Thesis - United Imaging is a leading manufacturer in the medical imaging equipment sector, with a growing market share and increasing government funding support for medical equipment procurement in China [7] - Anticipated rise in service-related revenue is expected to improve gross profit margins (GPM) [7] - Current trading near median P/E multiple since listing, with significant long-term growth potential due to expected revenue and profit margin growth [7] Price Target and Risks - 12-Month Price Target: Rmb 174, indicating a 36.9% upside from the current price of Rmb 127.08 [9] - Key Risks: - Chip supply chain disruptions - Raw material risks, particularly helium - Macroeconomic downturns in China - Potential Value-Based Pricing (VBP) risks [8] Conclusion - United Imaging's strong performance in FY25, driven by innovative products and overseas expansion, positions it well for future growth despite potential risks. The company maintains a "Buy" rating with a favorable price target reflecting its growth potential.